SCHULER JACK W purchased $666K of BDSX (indirect holdings)
SCHULER JACK W purchased 27,600 indirectly-held shares of BIODESIX INC (BDSX) at an average of $24.13 ($24.01–$24.25, $0.67M total) across 2 trades over 2026-08-10 to 2026-08-11.
How this was made
The 30-second read
Why it matters
The only new fact is the insider purchase size, price range, and post-transaction share count; there is no accompanying guidance, trial result, contract, or regulatory update.
Market read
Traders may note the insider buy as a mild sentiment input, but it does not change the fundamental information set from this text alone.
What to watch
The filing does not disclose the economic rationale, whether the purchase is funded by pre-existing arrangements, or whether other insiders are acting similarly.
Background
The article is an SEC Form 4 insider transaction disclosure for BIODESIX, filed on 2026-08-12, covering purchases made 2026-08-10 to 2026-08-11.
Ticker impact
SEC Form 4 shows 10% owner Schuler Jack W bought 27,600 shares of BIODESIX (indirect) for about $665,940 at $24.01 to $24.25.
Likely limited near-term impact; any effect would be small and short-lived unless followed by additional disclosures.
Form 4 insider purchases can be read as bullish, but the filing provides no new operating or financial information, and indirect holdings reduce interpretability.
Market effects
No sector-level signal; this is company-specific insider activity without new clinical, regulatory, or commercial details.
None indicated.
None indicated.
Counterpoint
Indirect holdings and lack of a 10b5-1 plan do not necessarily imply a strong forward view; it could reflect liquidity, estate, or rebalancing mechanics.
Key entities
- issuerBIODESIX
Company whose shares were purchased; Form 4 lists the insider as a 10% owner with indirect holdings.
- insiderSCHULER JACK W
10% owner reporting an open-market purchase of 27,600 shares across two trades.
